Structure-activity relationship study of oxindole-based inhibitors of cyclin-dependent kinases based on least-squares support vector machines

被引:56
作者
Li, Jiazhong
Liu, Huanxiang
Yao, Xiaojun [1 ]
Liu, Mancang
Hu, Zhide
Fan, Botao
机构
[1] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China
[2] Univ Paris 07, ITODYS, F-75005 Paris, France
关键词
structure-activity relationship (SAR); cyclin-dependent kinases (CDKs); inhibitor; linear discriminant analysis (LDA); least-squares support vector machines (LS-SVMs); oxindole;
D O I
10.1016/j.aca.2006.08.031
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The least-squares support vector machines (LS-SVMs), as an effective modified algorithm of support vector machine, was used to build structure-activity relationship (SAR) models to classify the oxindole-based inhibitors of cyclin-dependent kinases (CDKs) based on their activity. Each compound was depicted by the structural descriptors that encode constitutional, topological, geometrical, electrostatic and quantum-chemical features. The forward-step-wise linear discriminate analysis method was used to search the descriptor space and select the structural descriptors responsible for activity. The linear discriminant analysis (LDA) and nonlinear LS-SVMs method were employed to build classification models, and the best results were obtained by the LS-SVMs method with prediction accuracy of 100% on the test set and 90.91% for CDK1 and CDK2, respectively, as well as that of LDA models 95.45% and 86.36%. This paper provides an effective method to screen CDKs inhibitors. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 45 条
[1]  
[Anonymous], [No title captured], DOI DOI 10.1023/A:1009715923555
[2]  
[Anonymous], CODESSA TRAINING MAN
[3]  
[Anonymous], 1986, STAT ANAL
[4]  
[Anonymous], 0244 ESATSISTA
[5]   Pyrido[2,3-d]pyrimidin-7-one inhibitors of cyclin-dependent kinases [J].
Barvian, M ;
Boschelli, DH ;
Cossrow, J ;
Dobrusin, E ;
Fattaey, A ;
Fritsch, A ;
Fry, D ;
Harvey, P ;
Keller, P ;
Garrett, M ;
La, F ;
Leopold, W ;
McNamara, D ;
Quin, M ;
Trumpp-Kallmeyer, S ;
Toogood, P ;
Wu, ZP ;
Zhang, EL .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (24) :4606-4616
[6]   OPTIMAL CHARACTERIZATION OF STRUCTURE FOR PREDICTION OF PROPERTIES [J].
Basak, Subhash C. ;
Niemi, Gerald J. ;
Veith, Gilman D. .
JOURNAL OF MATHEMATICAL CHEMISTRY, 1990, 4 (01) :185-205
[7]   A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors [J].
Bhattacharjee, AK ;
Geyer, JA ;
Woodard, CL ;
Kathcart, AK ;
Nichols, DA ;
Prigge, ST ;
Li, ZY ;
Mott, BT ;
Waters, NC .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (22) :5418-5426
[8]   Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis [J].
Bramson, HN ;
Corona, J ;
Davis, ST ;
Dickerson, SH ;
Edelstein, M ;
Frye, SV ;
Gampe, RT ;
Harris, PA ;
Hassell, A ;
Holmes, WD ;
Hunter, RN ;
Lackey, KE ;
Lovejoy, B ;
Luzzio, MJ ;
Montana, V ;
Rocque, WJ ;
Rusnak, D ;
Shewchuk, L ;
Veal, JM ;
Walker, DH ;
Kuyper, LF .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (25) :4339-4358
[9]  
*CAMBR CORP, 1985, CHEMDRAW
[10]   Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists [J].
Chen, YNP ;
Sharma, SK ;
Ramsey, TM ;
Jiang, L ;
Martin, MS ;
Baker, K ;
Adams, PD ;
Bair, KW ;
Kaelin, WG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4325-4329